Investigation of Potential Lawsuits Involving Yaz and Yasmin

In response to the concerns over the link between Yaz and Yasmin and blood clots, Andrus Wagstaff PC is investigating potential lawsuits for victims.

Yaz and Yasmin, two similar new-generation birth control pills from Bayer, are among the best selling oral contraceptives in the world, but have been suspected of causing death or adverse effects. The primary difference between them is that a package of Yaz comes with 24 active pills and four inactive pills, while a package of Yasmin includes 21 active pills and seven inactive pills.

Thousands of injuries and about 100 deaths are linked to Yaz through some of the following severe side effects.

• Heart attack
• Deep vein thrombosis (blood clots in the legs)
• Pulmonary embolism (blockages in the lungs)
• Stroke
• Gallbladder disease

This is a major consumer safety concern. Lawsuits have alleged that Bayer failed to fully disclose and adequately warn patients and physicians of the risks associated with Yaz and Yasmin. Thousands have experienced life-threatening, health-destroying side-effects, such as blindness, depression and pulmonary embolism. A study from 2011 claims that Yasmin users experienced twice as much blood clot risk as women who used older contraceptives.